Vulvar Carcinoma: Standard of Care and Perspectives. (30-07-2024)

Overall Survival in Patients with Endometrial Cancer Treated with Dostarlimab Plus Carboplatin-Paclitaxel in the Randomized ENGOT-EN6/GOG-3031/RUBY Trial. (09-07-2024)

Dostarlimab For Primary Advanced Or Recurrent Endometrial Cancer. (16-04-2024)

Randomized Phase 3 Study Comparing Neoadiuvant Chemotherapy Followed By Surgery Versus Chemoradiation In Stage IB2-IIB Cervical Cancer: EORTC-5594. (05-03-2024)

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial